NFKB1 and colorectal carcinoma: In the present work, we tried to demonstrate this hypothesis by first investigating the NF-κB basal status in 3 CRC Cell lines (HT29, LoVo and DLD1) and their corresponding OXA-resistant derived sub-lines (HTOXAR3, LoVOXAR3 and DLDOXAR3, respectively).